#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	346	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1131	16.4	0	.	p	.	0	K29T	NONSYN	85	87	AAG	334	336	ACG	14;14;16	A;C;G	14;14;16	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	138	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c4.ctg.5	122	13.3	0	.	n	.	0	C897G	SNP	897	897	C	11	11	G	4	G	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	138	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c4.ctg.5	122	13.3	0	.	n	.	0	T898C	SNP	898	898	T	12	12	C	5	C	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	138	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c4.ctg.5	122	13.3	0	.	n	.	0	G906T	SNP	906	906	G	20	20	T	6	T	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	138	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c4.ctg.5	122	13.3	0	.	n	.	0	G908A	SNP	908	908	G	22	22	A	6	A	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	138	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c4.ctg.5	122	13.3	0	.	n	.	0	A918T	SNP	918	918	A	32	32	T	9	T	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	138	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c4.ctg.5	122	13.3	0	.	n	.	0	A943G	SNP	943	943	A	57	57	G	25	G	25	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	138	Chlamydophila_psittaci_16S	1507	111	92.79	Chlamydophila_psittaci_16S.l15.c4.ctg.5	122	13.3	0	.	n	.	0	G991T	SNP	991	991	G	105	105	T	21	T	20	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	L121Q	0	.	.	361	363	CTG	356	358	CTG	62;62;61	C;T;G,T	61;60;59,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	Q125E	0	.	.	373	375	CAG	368	370	CAG	71;72;71	C;A;G	70;71;71	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	Q125K	0	.	.	373	375	CAG	368	370	CAG	71;72;71	C;A;G	70;71;71	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	Q125R	0	.	.	373	375	CAG	368	370	CAG	71;72;71	C;A;G	70;71;71	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	Y161D	0	.	.	481	483	TAC	476	478	TAC	47;48;47	T;A;C	47;48;47	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	Y161N	0	.	.	481	483	TAC	476	478	TAC	47;48;47	T;A;C	47;48;47	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	Y161C	0	.	.	481	483	TAC	476	478	TAC	47;48;47	T;A;C	47;48;47	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	G317D	0	.	.	949	951	GGC	944	946	GGC	54;54;54	G;G;C,A	54;54;27,27	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1121	1123	GCA	26;26;25	G;C;A	26;25;25	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1121	1123	GCA	26;26;25	G;C;A	26;25;25	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1130	1132	GAA	26;26;25	G;A;A	26;26;25	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	0	HET	.	.	.	C216T	.	216	216	C	211	211	C	54	C,T	33,20	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	1161	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1161	52.6	0	HET	.	.	.	C99T	.	99	99	C	94	94	C	32	C,T	23,9	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	65	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	187	6.5	1	SNP	p	A376S	0	.	.	1126	1128	GCA	6	8	GCA	5;5;5	G;C;A	0;0;0	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	65	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	187	6.5	1	SNP	p	A376V	0	.	.	1126	1128	GCA	6	8	GCA	5;5;5	G;C;A	0;0;0	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	1306	Escherichia_coli_EF_Tu	1185	65	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	187	6.5	1	SNP	p	E379K	0	.	.	1135	1137	GAA	15	17	GAA	7;8;8	G;A;A	2;3;3	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	570	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1757	17.3	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1535	1537	AAA	9;9;9	A;A;A	9;9;9	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	558	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1724	17.2	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1258	1260	GAA	19;19;19	G;A;A	19;19;19	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	134	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	463	13.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	434	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1486	15.7	0	.	p	.	0	H2R	NONSYN	4	6	CAT	217	219	CGT	18;19;19	C;G;T	18;19;19	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	434	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1486	15.7	0	.	p	.	0	V30I	NONSYN	88	90	GTC	301	303	ATC	13;14;14	A;T;C	13;14;14	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	434	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1486	15.7	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1060	1062	GGC	22;23;24	G;G;C	22;23;23	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	686	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1975	18.6	0	.	p	.	0	R8S	NONSYN	22	24	AGA	181	183	AGC	8;7;7	A;G;C	8;7;7	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	686	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1975	18.6	0	.	p	.	0	I142L	NONSYN	424	426	ATA	583	585	CTA	14;14;13	C;T;A	14;14;13	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	686	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1975	18.6	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1102	1104	CAA	34;36;36	C;A;A	34;36;36	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	686	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1975	18.6	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1201	1203	GGT	21;19;19	G;G;T	21;19;19	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	686	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1975	18.6	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1771	1773	GTT	10;10;11	G;T;T	10;10;11	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	292	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1556	10.1	0	.	p	.	0	A125E	NONSYN	373	375	GCA	548	550	GAA	10;9;9	G;A;A	10;9;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	292	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1556	10.1	0	.	p	.	0	M185T	NONSYN	553	555	ATG	728	730	ACC	10;10;9	A;C;C	10;10;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	292	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1556	10.1	0	.	p	.	0	S225T	NONSYN	673	675	TCC	848	850	ACT	6;6;6	A;C;T	6;6;6	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	292	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1556	10.1	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1238	1240	ATC	7;9;9	A;T;C	7;9;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	436	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1356	17.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	16	36	TEM_1+	858	155	99.35	TEM_1+.l6.c30.ctg.1	155	2.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	394	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1073	19.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1294	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3351	20.6	0	.	p	.	0	T85I	NONSYN	253	255	ACC	428	430	ATC	16;16;17	A;T;C	16;16;17	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1294	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3351	20.6	0	.	p	.	0	V416I	NONSYN	1246	1248	GTC	1421	1423	ATC	16;16;16	A;T;C	16;15;14	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1294	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3351	20.6	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2141	2143	AAG	11;11;12	A;A;G	11;11;12	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	482	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1238	19.8	0	.	p	.	0	A22V	NONSYN	64	66	GCC	93	95	GTC	4;3;3	G;T;C	4;3;3	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	482	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1238	19.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	834	836	TGC	28;29;28	T;G,T;C	28;28,1;28	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1096	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2981	19.7	0	.	p	.	0	S46trunc	TRUNC	136	136	T	342	342	T	12	T	12	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1096	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2981	19.7	0	.	p	.	0	G148D	NONSYN	442	444	GGC	648	650	GAC	27;27;27	G;A;C	27;27;27	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1096	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2981	19.7	0	.	p	.	0	F240L	NONSYN	718	720	TTT	924	926	TTA	12;10;10	T;T;A	12;10;10	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1096	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2981	19.7	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1107	1109	AAT	10;10;10	A;A;T	10;10;10	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1096	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2981	19.7	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1894	1894	T	32	T	31	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	248	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1026	12.9	1	SNP	p	R45C	0	.	.	133	135	CGC	315	317	CGC	16;16;16	C;G;C	16;16;16	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	222	acrS	663	663	98.64	acrS.l6.c4.ctg.1	858	13.3	0	.	p	.	0	L34F	NONSYN	100	102	CTC	238	240	TTC	14;14;14	T;T;C	14;14;14	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	222	acrS	663	663	98.64	acrS.l6.c4.ctg.1	858	13.3	0	.	p	.	0	E122G	NONSYN	364	366	GAG	502	504	GGG	10;10;10	G;G;G	10;10;10	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	372	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1138	17.5	0	.	p	.	0	V136L	NONSYN	406	408	GTT	595	597	CTT	20;20;19	C;T;T	20;20;19	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1166	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3030	20.7	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2068	2070	GCA	27;27;28	G;C;A	26;27;28	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1166	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3030	20.7	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2329	2331	ACC	23;23;23	A;C;C	23;23;23	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1166	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3030	20.7	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2638	2640	GCC	15;16;19	G;C;C	15;16;19	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	646	arnA_1	1983	417	96.88	arnA_1.l6.c17.ctg.1	528	8.3	0	.	p	.	0	G37A	NONSYN	109	111	GGT	220	222	GCT	5;5;5	G;C;T	5;5;5	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	646	arnA_1	1983	417	96.88	arnA_1.l6.c17.ctg.1	528	8.3	0	.	p	.	0	D77E	NONSYN	229	231	GAT	340	342	GAG	4;4;4	G;A;G	4;4;4	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	646	arnA_1	1983	417	96.88	arnA_1.l6.c17.ctg.1	528	8.3	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	376	378	TGC	3;3;3	T;G;C	3;3;3	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	646	arnA_1	1983	1566	98.66	arnA_1.l6.c17.ctg.2	1773	16.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	78	80	GTT	7;7;7	G;T;T	7;7;7	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	646	arnA_1	1983	1566	98.66	arnA_1.l6.c17.ctg.2	1773	16.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	228	230	CAC	15;14;14	C;A;C	15;14;14	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	646	arnA_1	1983	1566	98.66	arnA_1.l6.c17.ctg.2	1773	16.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	513	515	ATG	28;28;29	A;T;G	27;28;29	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	513	646	arnA_1	1983	1566	98.66	arnA_1.l6.c17.ctg.2	1773	16.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1509	1511	CGC	15;15;16	C;G;C	15;15;16	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	270	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1054	13.3	0	.	p	.	0	S221T	NONSYN	661	663	AGC	855	857	ACC	7;7;7	A;C;C	7;7;7	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	270	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1054	13.3	0	.	p	.	0	P225S	NONSYN	673	675	CCG	867	869	TCG	10;10;10	T;C;G	10;10;10	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	282	baeR	723	723	97.79	baeR.l6.c4.ctg.1	1105	13.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	462	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1471	15.9	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1180	1182	AAA	11;11;11	A;A;A	11;11;11	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	462	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1471	15.9	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1192	1194	GAG	9;9;9	G;A;G	9;8;8	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	462	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1471	15.9	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1198	1200	CAC	10;9;10	C;A;C	10;9;10	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	462	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1471	15.9	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1252	1254	GAG	8;8;7	G;A;G	8;8;7	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	576	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1738	17.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	322	cpxR	699	699	99.43	cpxR.l6.c4.ctg.1	1082	15.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	400	cysB	975	975	99.28	cysB.l6.c30.ctg.1	1327	16.1	0	.	p	.	0	A146T	NONSYN	436	438	GCT	626	628	ACT	18;19;19	A;C;T	18;18;19	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	260	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	788	17.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	531	456	emrA	1173	1171	98.29	emrA.l15.c4.ctg.1	1184	19.6	0	.	p	.	0	I219V	NONSYN	655	657	ATC	653	655	GTC	31;29;28	G;T;C	30;28;27	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	658	emrB	1539	1539	99.74	emrB.l6.c30.ctg.1	1996	17.6	0	.	p	.	0	E197K	NONSYN	589	591	GAA	787	789	AAA	15;16;16	A,G;A;A	13,1;16;16	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	515	472	emrD	1191	1094	98.35	emrD.l15.c4.ctg.1	1289	18.3	0	.	p	.	0	G209S	NONSYN	625	627	GGC	820	822	AGC	22;21;19	A;G;C	22;21;19	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	515	472	emrD	1191	97	98.97	emrD.l15.c4.ctg.3	174	7.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	14	emrE_1	333	89	96.63	emrE_1.l15.c4.ctg.1	90	4.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	324	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1271	12.7	0	.	p	.	0	K176R	NONSYN	526	528	AAG	719	721	AGG	7;7;8	A;G;G	7;7;8	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	324	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1271	12.7	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1109	1111	GAC	8;8;8	G;A;C	8;8;8	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	278	emrR	531	531	100.0	emrR.l15.c4.ctg.1	882	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	544	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1918	15.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	204	evgA	615	615	99.19	evgA.l6.c4.ctg.1	1009	10.8	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	393	395	CTG	9;10;10	C;T;G	9;10;10	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	2490	97.87	evgS.l6.c30.ctg.1	2639	15.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	193	195	AAA	12;12;12	A;A;A	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	2490	97.87	evgS.l6.c30.ctg.1	2639	15.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	928	930	CAT	13;13;13	C;A;T	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	2490	97.87	evgS.l6.c30.ctg.1	2639	15.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	982	984	CAT	18;18;19	C;A;T	17;18;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	2490	97.87	evgS.l6.c30.ctg.1	2639	15.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1000	1002	AGA	11;11;11	A;G;A	11;11;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	2490	97.87	evgS.l6.c30.ctg.1	2639	15.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1015	1017	AAT	10;10;10	A;A;T	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	2490	97.87	evgS.l6.c30.ctg.1	2639	15.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1162	1164	TCC	6;5;5	T;C;C	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	2490	97.87	evgS.l6.c30.ctg.1	2639	15.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1327	1329	ATT	14;13;13	A;T;T	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	2490	97.87	evgS.l6.c30.ctg.1	2639	15.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1348	1350	GAT	9;9;9	G;A;T	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	2490	97.87	evgS.l6.c30.ctg.1	2639	15.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1462	1464	GTT	20;20;18	G;T;T	20;19;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	2490	97.87	evgS.l6.c30.ctg.1	2639	15.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1747	1749	CAC	16;15;13	C;A;C	16;15;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	443	97.52	evgS.l6.c30.ctg.2	511	12.9	0	.	p	.	0	T38I	NONSYN	112	114	ACA	180	182	ATA	2;2;2	A;T;A	2;2;2	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	443	97.52	evgS.l6.c30.ctg.2	511	12.9	0	.	p	.	0	L42V	NONSYN	124	126	CTA	192	194	GTA	3;3;3	G;T;A	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	443	97.52	evgS.l6.c30.ctg.2	511	12.9	0	.	p	.	0	A93T	NONSYN	277	279	GCG	345	347	ACG	13;13;13	A;C;G	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	443	97.52	evgS.l6.c30.ctg.2	511	12.9	0	.	p	.	0	A114E	NONSYN	340	342	GCA	408	410	GAA	9;8;8	G;A;A	9;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	443	97.52	evgS.l6.c30.ctg.2	511	12.9	0	.	p	.	0	T127A	NONSYN	379	381	ACT	447	449	GCT	11;11;11	G;C;T	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	443	97.52	evgS.l6.c30.ctg.2	511	12.9	0	.	p	.	0	N133D	NONSYN	397	399	AAT	465	467	GAT	11;11;11	G;A;T	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	374	97.59	evgS.l6.c30.ctg.3	375	8.9	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	95	97	CAG	5;5;4	C;A;G	5;5;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	512	1002	evgS	3594	374	97.59	evgS.l6.c30.ctg.3	375	8.9	0	.	p	.	0	I251V	NONSYN	751	753	ATT	233	235	GTT	5;5;5	G;T;T	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	330	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1160	15.2	1	SNP	p	P64R	0	.	.	190	192	CCA	301	303	CCA	28;29;28	C;C;A	27;29;26	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	330	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1160	15.2	1	SNP	p	P64S	0	.	.	190	192	CCA	301	303	CCA	28;29;28	C;C;A	27;29;26	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	330	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1160	15.2	1	SNP	p	P64L	0	.	.	190	192	CCA	301	303	CCA	28;29;28	C;C;A	27;29;26	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	330	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1160	15.2	1	SNP	p	P64A	0	.	.	190	192	CCA	301	303	CCA	28;29;28	C;C;A	27;29;26	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	330	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1160	15.2	1	SNP	p	P64H	0	.	.	190	192	CCA	301	303	CCA	28;29;28	C;C;A	27;29;26	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	202	gadE	528	528	100.0	gadE.l15.c30.ctg.1	938	11.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	16	62	gadW	729	131	96.95	gadW.l15.c17.ctg.1	131	10.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	224	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1034	11.5	0	.	p	.	0	F53L	NONSYN	157	159	TTC	306	308	TTA	10;10;10	T;T;A	10;10;10	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	224	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1034	11.5	0	.	p	.	0	V79I	NONSYN	235	237	GTT	384	386	ATT	11;11;11	A;T;T	11;11;11	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	224	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1034	11.5	0	.	p	.	0	R246G	NONSYN	736	738	AGA	885	887	GGA	5;8;9	G;G;A	5;8;9	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	224	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1034	11.5	0	.	p	.	0	S248P	NONSYN	742	744	TCG	891	893	CCG	9;9;9	C;C;G	9;9;9	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1202	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2902	21.9	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2102	2104	GAA	18;18;18	G;A;A	18;18;18	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1202	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2902	21.9	1	SNP	p	S83L	0	.	.	247	249	TCG	317	319	TCG	22;25;25	T;C;G	21;25;25	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1202	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2902	21.9	1	SNP	p	S83W	0	.	.	247	249	TCG	317	319	TCG	22;25;25	T;C;G	21;25;25	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1202	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2902	21.9	1	SNP	p	S83I	0	.	.	247	249	TCG	317	319	TCG	22;25;25	T;C;G	21;25;25	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1202	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2902	21.9	1	SNP	p	D87G	0	.	.	259	261	GAC	329	331	GAC	27;27;28	G;A,G;C	27;25,1;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1202	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2902	21.9	1	SNP	p	D87Y	0	.	.	259	261	GAC	329	331	GAC	27;27;28	G;A,G;C	27;25,1;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1202	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2902	21.9	1	SNP	p	D87N	0	.	.	259	261	GAC	329	331	GAC	27;27;28	G;A,G;C	27;25,1;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1202	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2902	21.9	1	SNP	p	D87V	0	.	.	259	261	GAC	329	331	GAC	27;27;28	G;A,G;C	27;25,1;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1202	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	2902	21.9	1	SNP	p	D87H	0	.	.	259	261	GAC	329	331	GAC	27;27;28	G;A,G;C	27;25,1;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	974	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2831	18.4	1	SNP	p	R136C	0	.	.	406	408	CGC	614	616	CGC	21;21;22	C;G;C	21;21;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	974	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2831	18.4	1	SNP	p	R136H	0	.	.	406	408	CGC	614	616	CGC	21;21;22	C;G;C	21;21;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	974	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2831	18.4	1	SNP	p	R136L	0	.	.	406	408	CGC	614	616	CGC	21;21;22	C;G;C	21;21;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	974	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2831	18.4	1	SNP	p	R136G	0	.	.	406	408	CGC	614	616	CGC	21;21;22	C;G;C	21;21;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	974	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2831	18.4	1	SNP	p	R136S	0	.	.	406	408	CGC	614	616	CGC	21;21;22	C;G;C	21;21;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	974	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2831	18.4	1	SNP	p	R136I	0	.	.	406	408	CGC	614	616	CGC	21;21;22	C;G;C	21;21;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	974	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2831	18.4	1	SNP	p	R136E	0	.	.	406	408	CGC	614	616	CGC	21;21;22	C;G;C	21;21;22	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	218	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	950	12.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	415	417	CCG	14;15;16	C;C;G	14;15;16	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	218	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	950	12.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	568	570	GCC	19;19;19	G;C;C	19;19;19	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	398	leuO	945	945	99.26	leuO.l6.c17.ctg.1	1278	16.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	171	173	TCA	14;14;17	T;C;A,G	14;14;16,1	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	168	marA	384	384	99.74	marA.l6.c30.ctg.1	798	11.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	316	318	AGC	7;6;6	A;G;C	7;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	418	420	CAT	2;2;2	C;A;T	2;2;2	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	V45E	0	.	.	133	135	GTG	142	144	GTG	10;10;10	G;T;G	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	I49S	0	.	.	145	147	ATC	154	156	ATC	10;11;11	A;T;C	10;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	A70T	0	.	.	208	210	GCA	217	219	GCA	9;9;9	G;C;A	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	R73S	0	.	.	217	219	CGT	226	228	CGT	7;6;4	C;G;T	7;6;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	R73C	0	.	.	217	219	CGT	226	228	CGT	7;6;4	C;G;T	7;6;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	R77L	0	.	.	229	231	CGC	238	240	CGC	7;6;6	C;G;C	7;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	R77C	0	.	.	229	231	CGC	238	240	CGC	7;6;6	C;G;C	7;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	L78M	0	.	.	232	234	CTG	241	243	CTG	6;6;6	C;T;G	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	R94H	0	.	.	280	282	CGC	289	291	CGC	7;6;6	C;G;C	7;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	R94S	0	.	.	280	282	CGC	289	291	CGC	7;6;6	C;G;C	7;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	100	marR	435	415	97.59	marR.l15.c30.ctg.1	424	9.3	1	SNP	p	V96E	0	.	.	286	288	GTA	295	297	GTA	6;6;6	G;T;A	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	282	mdfA	1233	1083	97.41	mdfA.l15.c4.ctg.1	1217	11.5	0	.	p	.	0	E52D	NONSYN	154	156	GAG	4	6	GAT	3;3;3	G;A;T	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	282	mdfA	1233	1083	97.41	mdfA.l15.c4.ctg.1	1217	11.5	0	.	p	.	0	N59T	NONSYN	175	177	AAC	25	27	ACC	3;4;4	A;C;C	2;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	282	mdfA	1233	1083	97.41	mdfA.l15.c4.ctg.1	1217	11.5	0	.	p	.	0	I68L	NONSYN	202	204	ATA	52	54	TTA	6;6;6	T;T;A	5;6;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	282	mdfA	1233	1083	97.41	mdfA.l15.c4.ctg.1	1217	11.5	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	193	195	CAG	12;12;11	C;A;G	12;12;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	282	mdfA	1233	1083	97.41	mdfA.l15.c4.ctg.1	1217	11.5	0	.	p	.	0	D128A	NONSYN	382	384	GAC	232	234	GCC	12;14;13	G;C;C	12;14;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	282	mdfA	1233	1083	97.41	mdfA.l15.c4.ctg.1	1217	11.5	0	.	p	.	0	S163A	NONSYN	487	489	TCG	337	339	GCG	8;7;7	G;C;G	8;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	282	mdfA	1233	1083	97.41	mdfA.l15.c4.ctg.1	1217	11.5	0	.	p	.	0	L231V	NONSYN	691	693	CTT	541	543	GTT	4;4;5	G;T;T	4;4;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	282	mdfA	1233	1083	97.41	mdfA.l15.c4.ctg.1	1217	11.5	0	.	p	.	0	R285fs	FSHIFT	853	853	C	703	703	C	8	C	8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	282	mdfA	1233	97	96.91	mdfA.l15.c4.ctg.2	100	5.4	0	.	p	.	0	R36I	NONSYN	106	108	AGG	89	91	ATC	3;3;3	A;T;C	3;3;3	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	356	mdtA	1248	654	98.47	mdtA.l15.c4.ctg.1	778	14.4	0	.	p	.	0	P257T	NONSYN	769	771	CCG	178	180	ACG	10;10;10	A;C;G	10;10;10	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	356	mdtA	1248	306	96.73	mdtA.l15.c4.ctg.2	309	9.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	11	13	ATG	3;3;3	A;T;G	3;3;3	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	356	mdtA	1248	306	96.73	mdtA.l15.c4.ctg.2	309	9.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	104	106	ACC	9;9;9	A;C;C	9;9;9	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	356	mdtA	1248	171	97.66	mdtA.l15.c4.ctg.3	171	10.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	126	128	ATC	9;8;8	A;T;C	9;8;8	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1358	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3455	21.1	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1941	1943	ACC	32;30;29	A;C;C	32;30;29	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1358	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3455	21.1	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2334	2336	CAA	18;16;16	C;A;A	18;16;15	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1358	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3455	21.1	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2502	2504	ATT	19;19;18	A;T;T	19;19;18	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1358	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3455	21.1	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2586	2588	GTT	12;12;14	G;T;T	12;12;14	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1358	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3455	21.1	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2694	2696	GAG	14;14;13	G;A;G	14;14;13	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1358	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3455	21.1	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2922	2924	ATG	10;10;12	A;T;G	10;10;12	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1358	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3455	21.1	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3057	3059	GAT	15;15;16	G;A;T	15;15;16	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1176	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3153	19.7	0	.	p	.	0	I46M	NONSYN	136	138	ATC	190	192	ATG	7;7;7	A;T;G	7;7;7	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1176	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3153	19.7	0	.	p	.	0	V208I	NONSYN	622	624	GTC	676	678	ATC	20;22;22	A;T;C	20;22;22	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1176	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3153	19.7	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	2992	2994	CAC	5;5;5	C;A;C	5;5;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1176	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3153	19.7	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	2995	2997	CTC	5;6;6	C;T;C	5;6;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	556	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1758	16.9	0	.	p	.	0	D3E	NONSYN	7	9	GAT	157	159	GAA	11;11;11	G;A;A	11;11;11	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	556	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1758	16.9	0	.	p	.	0	T226A	NONSYN	676	678	ACG	826	828	GCG	19;19;19	G;C;G	19;19;19	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	556	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1758	16.9	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1168	1170	ATC	21;21;22	A;T;C	21;21;22	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	556	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1758	16.9	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1471	1473	TTT	23;23;23	T;T;T	23;23;23	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	526	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1562	18.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1324	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3543	20.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1124	1126	ACC	16;16;16	A;C,A;C	16;14,1;16	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1324	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3543	20.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2366	2368	GAC	37;36;37	G;A;C	37;36;37	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	466	mdtG	1227	1047	99.33	mdtG.l6.c30.ctg.1	1573	14.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	578	580	ATC	18;16;17	A;T;C	18;16;16	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	466	mdtG	1227	182	99.45	mdtG.l6.c30.ctg.2	323	7.8	0	.	p	.	0	E5G	NONSYN	13	15	GAA	149	151	GGA	3;3;4	G;G;A	3;3;4	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	410	mdtH	1209	1209	98.18	mdtH.l6.c17.ctg.1	1515	14.5	0	.	p	.	0	G134C	NONSYN	400	402	GGT	554	556	TGT	18;20;20	T;G;T	18;20;20	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	410	mdtH	1209	1209	98.18	mdtH.l6.c17.ctg.1	1515	14.5	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1124	1126	TTG	13;13;14	T;T;G	13;13;14	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	410	mdtH	1209	1209	98.18	mdtH.l6.c17.ctg.1	1515	14.5	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1334	1336	ACG	4;4;4	A;C;G	4;4;4	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	478	mdtL	1176	1176	98.38	mdtL.l6.c4.ctg.1	1567	16.2	0	.	p	.	0	A185S	NONSYN	553	555	GCC	761	763	TCC	14;16;16	T;C;C	13;16;16	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	314	mdtN	1032	1032	98.06	mdtN.l6.c30.ctg.1	1119	13.7	0	.	p	.	0	V119I	NONSYN	355	357	GTT	383	385	ATT	9;10;11	A;T;T	9;10;11	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	V11M	NONSYN	31	33	GTG	122	124	ATG	13;13;13	A;T;G	13;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	T33I	NONSYN	97	99	ACC	188	190	ATC	11;11;11	A;T;C	10;10;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	C116R	NONSYN	346	348	TGC	437	439	CGC	15;15;15	C;G;C	15;15;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	N238S	NONSYN	712	714	AAC	803	805	AGC	19;19;19	A;G;C	19;19;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1004	1006	GTG	15;15;15	G;T;G	14;14;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1067	1069	AAC	5;5;5	A;A;C	5;4;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1112	1114	GTC	11;11;12	G;T;C	10;10;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1142	1144	ATA	16;16;16	A;T;A	16;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1250	1252	TCT	17;18;18	T;C;T	17;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1637	1639	GCG	15;15;15	G;C;G	15;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	768	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2342	17.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1850	1852	ATC	16;17;19	A,C;T;C	15,1;17;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	486	mdtP	1467	1467	97.96	mdtP.l6.c17.ctg.1	1682	15.1	0	.	p	.	0	S129A	NONSYN	385	387	TCA	449	451	GCG	18;19;19	G;C;G	18;18;18	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	486	mdtP	1467	1467	97.96	mdtP.l6.c17.ctg.1	1682	15.1	0	.	p	.	0	A187T	NONSYN	559	561	GCC	623	625	ACC	14;14;14	A;C;C	14;14;14	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	486	mdtP	1467	1467	97.96	mdtP.l6.c17.ctg.1	1682	15.1	0	.	p	.	0	H211R	NONSYN	631	633	CAC	695	697	CGC	15;14;15	C;G;C	15;14;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	486	mdtP	1467	1467	97.96	mdtP.l6.c17.ctg.1	1682	15.1	0	.	p	.	0	V250A	NONSYN	748	750	GTT	812	814	GCT	8;9;9	G;C;T	7;9;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	486	mdtP	1467	1467	97.96	mdtP.l6.c17.ctg.1	1682	15.1	0	.	p	.	0	R278K	NONSYN	832	834	AGA	896	898	AAA	9;10;11	A;A;A	9;10;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	486	mdtP	1467	1467	97.96	mdtP.l6.c17.ctg.1	1682	15.1	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	914	916	CGA	10;10;13	C;G;A	10;10;13	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	486	mdtP	1467	1467	97.96	mdtP.l6.c17.ctg.1	1682	15.1	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1079	1081	GCC	7;7;7	G;C;C	7;7;7	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	486	mdtP	1467	1467	97.96	mdtP.l6.c17.ctg.1	1682	15.1	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1091	1093	GAT	11;12;12	G;A;T	11;12;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	486	mdtP	1467	1467	97.96	mdtP.l6.c17.ctg.1	1682	15.1	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1508	1510	GCT	5;5;5	G;C;T	5;5;5	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1270	mfd	3447	3447	99.16	mfd.l6.c30.ctg.1	3784	18.0	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1471	1473	AAG	16;16;16	A;A;G	16;16;16	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1270	mfd	3447	3447	99.16	mfd.l6.c30.ctg.1	3784	18.0	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2548	2550	CTG	24;22;23	C;T;G	24;22;23	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	60	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	164	9.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	836	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2013	22.2	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1009	1011	AAC	24;25;26	A;A;C	24;25;26	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	836	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2013	22.2	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1555	1557	ATA	27;27;26	A;T;A	26;26;26	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	484	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1624	15.9	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1276	1278	GAT	19;20;20	G;A;T	19;20;20	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	484	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1624	15.9	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1279	1281	CTG	20;22;22	C;T;G	20;22;22	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	184	nfsA	723	405	99.01	nfsA.l15.c30.ctg.1	764	12.5	0	.	p	.	0	R27C	NONSYN	79	81	CGT	221	223	TGT	15;15;14	T;G;T	15;15;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	184	nfsA	723	405	99.01	nfsA.l15.c30.ctg.1	764	12.5	0	.	p	.	0	I117T	NONSYN	349	351	ATC	491	493	ACC	14;14;13	A;C;C	14;14;13	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	184	nfsA	723	405	99.01	nfsA.l15.c30.ctg.1	764	12.5	1	SNP	p	R15C	0	.	.	43	45	CGC	185	187	CGC	22;22;23	C;G;C	22;22;23	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	184	nfsA	723	405	99.01	nfsA.l15.c30.ctg.1	764	12.5	1	SNP	p	S33R	0	.	.	97	99	AGC	239	241	AGC	13;13;12	A;G;C	13;13;12	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	184	nfsA	723	405	99.01	nfsA.l15.c30.ctg.1	764	12.5	1	SNP	p	G131D	0	.	.	391	393	GGC	533	535	GGC	13;12;11	G;G;C	13;12;9	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	550	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1481	19.9	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1120	1122	GAG	17;17;18	G;A;G	17;17;18	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	550	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1481	19.9	1	SNP	p	G141E	0	.	.	421	423	GGT	607	609	GGT	28;28;27	G;G;T	28;28;27	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	550	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1481	19.9	1	SNP	p	G141D	0	.	.	421	423	GGT	607	609	GGT	28;28;27	G;G;T	28;28;27	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	550	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1481	19.9	1	SNP	p	R154D	0	.	.	460	462	CGT	646	648	CGT	29;29;29	C,T;G;T	28,1;29;29	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	550	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1481	19.9	1	SNP	p	R154A	0	.	.	460	462	CGT	646	648	CGT	29;29;29	C,T;G;T	28,1;29;29	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	20.2	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1820	1822	GTG	21;23;22	G;T;G	21;23;22	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	20.2	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1847	1849	TCG	30;31;32	T;C;G	27;30;31	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	20.2	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2462	2464	AAC	13;13;13	A;A;C	13;13;13	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	20.2	1	SNP	p	A85T	0	.	.	253	255	GCG	476	478	GCG	20;20;20	G;C;G	18;19;19	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	20.2	1	SNP	p	D111H	0	.	.	331	333	GAT	554	556	GAT	18;18;18	G;A;T	18;18;17	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	996	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2636	20.2	1	SNP	p	S129P	0	.	.	385	387	TCC	608	610	TCC	14;15;16	T;C;C	14;15;16	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	638	parE_1	1893	1893	97.52	parE_1.l6.c17.ctg.1	2184	15.2	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1436	1438	AAC	17;18;20	A;A;C	17;18;20	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	638	parE_1	1893	1893	97.52	parE_1.l6.c17.ctg.1	2184	15.2	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1445	1447	GAT	23;27;25	G;A;T	23;27;25	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	614	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1780	18.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	793	795	CAG	16;16;16	C;A;G	16;16;16	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	614	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1780	18.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1267	1269	GAT	20;19;16	G;A;T	20;18;16	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	V146F	0	.	.	436	438	GTT	642	644	GTT	19;19;19	G;T;T	19;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1743	1745	CAG	31;32;33	C;A;G	31;32;33	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1743	1745	CAG	31;32;33	C;A;G	31;32;33	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1782	1784	CAC	28;28;28	C;A;C	28;28;28	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1791	1793	CGT	24;22;22	C;G;T	24;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1791	1793	CGT	24;22;22	C;G;T	24;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1797	1799	TCC	21;22;21	T;C;C	21;22;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1803	1805	CTC	21;22;22	C;T;C	21;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1893	1895	ACC	23;23;24	A;C;C	23;23;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1896	1898	CCT	24;25;25	C;C;T	24;25;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1786	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4416	21.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2265	2267	CGT	26;25;22	C;G;T	26;24;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	.	n	.	0	A226G	SNP	226	226	A	377	377	G	155	G	154	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	1	SNP	n	A794T	0	.	.	794	794	A	945	945	A	137	A	136	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	1	SNP	n	A794G	0	.	.	794	794	A	945	945	A	137	A	136	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	1	SNP	n	G926A	0	.	.	926	926	G	1077	1077	G	153	G	152	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	1	SNP	n	G926C	0	.	.	926	926	G	1077	1077	G	153	G	152	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	1	SNP	n	G926T	0	.	.	926	926	G	1077	1077	G	153	G	152	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	1	SNP	n	A1519T	0	.	.	1519	1519	A	1670	1670	A	119	A	118	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	1	SNP	n	A1519C	0	.	.	1519	1519	A	1670	1670	A	119	A	118	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	1	SNP	n	A1519G	0	.	.	1519	1519	A	1670	1670	A	119	A	118	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	G1002A	.	1002	1002	G	1153	1153	G	155	G,A	105,50	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	G1006C	.	1006	1006	G	1157	1157	G	155	G,C	105,49	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	A79G	.	79	79	A	230	230	A	146	A,G	106,38	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	C719T	.	719	719	C	870	870	C	133	C,T	82,49	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	T273A	.	273	273	T	424	424	T	138	T,A	103,32	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	T1010C	.	1010	1010	T	1161	1161	T	164	T,C	113,49	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	C1038T	.	1038	1038	C	1189	1189	C	164	C,T	99,64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	C183T	.	183	183	C	334	334	C	132	C,T	86,46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	T90C	.	90	90	T	241	241	T	144	T,C	104,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	A250T	.	250	250	A	401	401	A	137	A,T	103,34	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	G474A	.	474	474	G	625	625	G	150	G,A	114,34	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	A253T	.	253	253	A	404	404	A	140	A,T	106,34	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4878	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.2	1882	136.0	0	HET	.	.	.	C194T	.	194	194	C	345	345	C	138	C,T	113,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	192	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	850	11.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	210	soxR	465	465	100.0	soxR.l15.c4.ctg.1	817	13.7	1	SNP	p	R20H	0	.	.	58	60	CGC	222	224	CGC	23;24;25	C;G;C	23;24;25	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	210	soxR	465	465	100.0	soxR.l15.c4.ctg.1	817	13.7	1	SNP	p	G121D	0	.	.	361	363	GGT	525	527	GGT	24;24;23	G;G;T	24;24;23	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	174	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	679	13.5	1	SNP	p	A12S	0	.	.	34	36	GCA	198	200	GCA	16;16;16	G;C;A	16;16;16	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	630	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1867	18.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
